Klein Roger M. 4
4 · Evoke Pharma Inc · Filed Nov 7, 2025
Insider Transaction Report
Form 4
Evoke Pharma IncEVOK
Klein Roger M.
10% Owner
Transactions
- Sale
Common Stock
2025-11-06$10.66/sh−5,000$53,285→ 29,000 total(indirect: By IRA) - Sale
Common Stock
2025-11-06$10.65/sh−4,000$42,600→ 125,000 total(indirect: By Trust)
Footnotes (3)
- [F1]Price reflects the weighted average sale price for the shares, which were sold in multiple transactions at prices that ranged from $10.65 to $10.66. Upon request, the Reporting Person will provide information regarding the number of shares sold at each price within the range to the Issuer, any security holder of the issuer, or the SEC staff.
- [F2]Represents securities of the Issuer owned directly by Mr. Klein's Roth Individual Retirement Account ("IRA").
- [F3]Represents securities of the Issuer owned directly by Krieger Charitable Trust (the "Trust"). Mr. Klein, as sole trustee of the Trust, may be deemed to beneficially own the securities of the Issuer owned directly by the Trust. Mr. Klein disclaims beneficial ownership of the securities of the Issuer reported herein, except to the extent of his pecuniary interest therein, and the filing of this Form 4 shall not be construed as an admission that Mr. Klein is a beneficial owner of the securities of the Issuer reported herein.